Pharmaceutical composition with fexofenadine hydrochloride and preparation method of pharmaceutical composition

A technology of fexofenadine and its composition, which is applied in the field of medicine and can solve problems such as difficult control of disintegration time limit and dissolution rate, inconvenient production, storage and transportation, and complicated preparation process

Active Publication Date: 2014-03-05
ZHEJIANG WAN SHENG PHARMA CO LTD
View PDF4 Cites 5 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Orally disintegrating tablets are required to be high-efficiency and low-dose drugs, not suitable for drugs with a strong bitter taste or pungent taste. The preparation process is complicated, and the disintegration time limit and dissolution rate are difficult to control. Chen Bengao
Although the oral suspension overcomes the above disadvantages, preservatives must be added to the oral suspension to prevent the growth of bacteria, and it is inconvenient to produce, store and transport

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Pharmaceutical composition with fexofenadine hydrochloride and preparation method of pharmaceutical composition
  • Pharmaceutical composition with fexofenadine hydrochloride and preparation method of pharmaceutical composition
  • Pharmaceutical composition with fexofenadine hydrochloride and preparation method of pharmaceutical composition

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0026] Product prescription (Table 1):

[0027]

[0028]

[0029] A total of 1000 bags of production process: pass fexofenadine hydrochloride and suspending agent through an 80-mesh sieve, pass each component of filler, sweetener, flavor and glidant through a 100-mesh sieve, and pass the sieved ingredients Mix evenly and dispense.

Embodiment 2

[0031] Product prescription (Table 2):

[0032]

[0033] A total of 1000 bags of production process: pass fexofenadine hydrochloride and suspending agent through an 80-mesh sieve, pass each component of filler, sweetener, flavor and glidant through a 100-mesh sieve, and pass the sieved ingredients Mix evenly and dispense.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a pharmaceutical composition with fexofenadine hydrochloride. The composition is composed of the following components: 1-12% of fexofenadine hydrochloride as an active ingredient, 1-10% of suspending aid, 5-85% of filler, 1-10% of sweetening agent, 0.01-10% of essence and a conventional amount of flow aid, wherein the composition exists in a form of a dry suspension. The fexofenadine hydrochloride suspension provided by the invention has the advantages of high dispersity, uniformity in distribution, rapidness in absorption, high bioavailability, good taste, stability and the like.

Description

technical field [0001] The invention relates to medicines, in particular to a new dosage form of fexofenadine hydrochloride and a preparation method thereof. Background technique [0002] [0003] CAS registration number: 138452-21-8 [0004] Fexofenadine, the active metabolite of terfenadine, is a potent H1 receptor antagonist without the cardiotoxicity of its predecessor. In addition to blocking H1 receptors, studies in vitro and in vivo have also shown that fexofenadine can induce allergic inflammatory reactions mediated by mast cells, basophils, epithelial cells, eosinophils and lymphocytes. Fexofenadine has been shown to have anti-inflammatory activity and to inhibit the expression of ICAM-1 on nasal epithelial cells in vitro. For the treatment of seasonal allergic rhinitis and chronic idiopathic urticaria. [0005] The traditional dosage forms of fexofenadine for clinical selection include capsules, tablets, orally disintegrating tablets, and oral suspensions. C...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K9/14A61K31/445A61P37/08A61P11/02A61P17/00
Inventor 金璐杜军单瑞平桂盼蒋定宇杨必伟
Owner ZHEJIANG WAN SHENG PHARMA CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap